サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1699145

NGSベースのRNAシーケンス市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、コンポーネント、機能、展開、段階

NGS Based RNA Sequencing Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Component, Functionality, Deployment, Stage

出版日
ページ情報
英文 465 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
NGSベースのRNAシーケンス市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、コンポーネント、機能、展開、段階
出版日: 2025年04月01日
発行: Global Insight Services
ページ情報: 英文 465 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

NGSベースのRNAシーケンス市場は、2024年の33億1,000万米ドルから2034年には144億7,000万米ドルに拡大し、約15.9%のCAGRで成長すると予測されます。この市場には、RNA分析に次世代シーケンサーを利用する技術とサービスが含まれ、遺伝子発現、トランスクリプトミクス、細胞応答に関する包括的な洞察を記載しています。この市場を牽引するのは、個別化医療、バイオテクノロジー、ゲノム研究の進歩です。主要動向には、シーケンスの精度向上、コスト削減、疾患診断や医薬品開発における用途の拡大などがあり、RNAシーケンスは現代の医療やライフサイエンスにおいて極めて重要なツールと位置付けられています。

市場概要

NGSベースのRNAシーケンス市場は、ゲノム研究と個別化医療の進展に後押しされ、力強い拡大を経験しています。シーケンス技術セグメントは、主にその技術的優位性と正確かつ包括的なRNA分析を可能にする重要な役割により、主要セグメントとして浮上しています。このセグメントの優位性は、精度、スピード、費用対効果を向上させるシーケンスプラットフォームにおける継続的な技術革新によってさらに強化され、それによって研究と臨床現場での採用が促進されています。このような状況の中で、シングルセルRNAシーケンスのサブセグメントが勢いを増しており、細胞の不均一性と疾患メカニズムに関するこれまでにない洞察を提供しています。診断や治療開発に革命をもたらす可能性があることから、市場への影響力が強調されています。一方、データ分析サービスセグメントは、シーケンスデータの複雑化と先進的バイオインフォマティクスツールの需要に後押しされて急成長しています。これらの新興サブセグメントが成熟するにつれて、NGSベースのRNAシーケンス市場の軌道に大きな影響を与え、イノベーションを促進し、用途を拡大する準備が整っています。

市場セグメンテーション
タイプ 全トランスクリプトームシーケンス、対象RNAシーケンス、小分子RNAシーケンス、シングルセルRNAシーケンス
製品 シーケンスプラットフォーム、キットと試薬、ソフトウェア
サービス データ分析、シーケンスサービス
技術 合成シーケンス、イオンセミコンダクターシーケンス、1分子リアルタイムシーケンス、ナノポアシーケンス
用途セグメント 臨床診断、創薬開発、農業ゲノム、バイオマーカー探索
エンドユーザー 学術研究機関、製薬・バイオテクノロジー企業、病院クリニック、受託研究機関
コンポーネント ハードウェア、ソフトウェア、サービス
機能 遺伝子発現プロファイリング、De Novoトランスクリプトームアセンブリ、エピジェネティクス
展開 オンプレミス、クラウドベース
段階 研究、臨床

NGSベースのRNAシーケンス市場は、研究機関と学術機関が支配的で、臨床と診断ラボがそれに続くという特徴があります。この分布は主に、正確なゲノム分析に対する需要の高まりと、個別化医療におけるRNAシーケンスの応用の拡大によってもたらされています。北米は依然として市場導入の最前線にあり、欧州とアジア太平洋は医療インフラと研究イニシアチブの進歩により大きな成長の可能性を示しています。Illumina、Thermo Fisher Scientific、Agilent Technologiesなどの主要企業は、シーケンスの精度と効率を高めるために革新的な技術に投資しています。競合情勢はさらに、北米と欧州の規制枠組みによって形成されており、これらは市場標準を規定し、採用率に影響を与えています。今後については、シーケンスプラットフォームの技術革新とデータ分析のための人工知能の統合により、市場は堅調な拡大が見込まれます。しかし、データのプライバシーに関する懸念やシーケンス技術の高コストといった課題は依然として残っています。バイオインフォマティクスの継続的な進歩と精密医療に対する需要の高まりは、NGSベースのRNAシーケンス市場に大きな成長機会をもたらしています。

主要動向と促進要因

NGSベースのRNAシーケンス市場は、主に個別化医療と精密腫瘍学に対する需要の高まりによって、力強い拡大を経験しています。慢性疾患の蔓延が進むにつれて先進的診断ツールが必要となり、RNAシーケンス技術の採用を後押ししています。主要動向には、人工知能と機械学習の統合、データ分析能力の強化、複雑なゲノムデータのより正確な解釈などがあります。さらに、シーケンス技術のコスト低下により、RNAシーケンスがより幅広い研究機関や臨床検査機関で利用しやすくなっています。このような技術の民主化はイノベーションを促進し、創薬やバイオマーカー同定など、さまざまなセグメントにおける新規用途の探求を促しています。公的、私的を問わず共同研究イニシアチブの高まりは、この市場の進歩をさらに加速させています。遺伝子の発現と制御を理解する上でトランスクリプトミクスへの注目が高まっていることも、大きな推進力となっています。この焦点は、治療標的の特定や新たな治療法の開発におけるブレークスルーにつながっています。医療のインフラが急速に進歩し、最先端のゲノム技術の導入が重視されるようになっている新興市場には、多くのビジネス機会が存在します。ユーザーフレンドリーでスケーラブルなシーケンスソリューションに投資する企業は、このような急成長する機会を活用するのに有利な立場にあります。

抑制要因と課題

NGSベースのRNAシーケンス市場は、いくつかの重大な抑制要因と課題に直面しています。主要障害は、シーケンス技術に関連する高コストであり、これは小規模なラボや研究機関のアクセスを制限しています。さらに、データ解釈の複雑さには専門的な知識が必要であり、多くの場合、トレーニングや熟練した人材への追加投資が必要となります。遺伝子情報に関する厳しい規制が研究や共同研究の妨げとなるため、データのプライバシーに関する懸念も課題となります。さらに、技術進歩のペースが速いと陳腐化する可能性があり、競合を維持するためには継続的な投資が必要となります。最後に、NGS技術を既存のワークフローに統合することは煩雑であり、適応のために多大な時間とリソースを必要とすることがあります。これらの課題は総体的に、NGSベースのRNAシーケンス市場の普及と成長の妨げとなっています。

目次

第1章 NGSベースのRNA-シーケンス市場概要

  • 調査目的
  • NGSベースのRNAシーケンス市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年と通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 NGSベースのRNA-シーケンス市場展望

  • NGSベースのRNA-セシーケンス市場セグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 NGSベースのRNAシーケンス市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • 使用事例分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析

第6章 NGSベースのRNAシーケンス市場規模

  • NGSベースのRNAシーケンス市場規模：金額別
  • NGSベースのRNAシーケンス市場規模：数量別

第7章 NGSベースのRNAシーケンス市場：タイプ別

  • 市場概要
  • 全トランスクリプトームシーケンス
  • 対象RNAシーケンス
  • 小分子RNAシーケンス
  • シングルセルRNAシーケンス
  • その他

第8章 NGSベースのRNAシーケンス市場：製品別

  • 市場概要
  • シーケンスプラットフォーム
  • キットと試薬
  • ソフトウェア
  • その他

第9章 NGSベースのRNAシーケンス市場：サービス別

  • 市場概要
  • データ分析
  • シーケンスサービス
  • その他

第10章 NGSベースのRNAシーケンス市場：技術別

  • 市場概要
  • 合成によるシーケンス
  • イオン半導体シーケンス
  • 1分子リアルタイムシーケンス
  • ナノポアシーケンス
  • その他

第11章 NGSベースのRNAシーケンス市場：用途別

  • 市場概要
  • 臨床診断
  • 創薬・医薬品開発
  • 農業ゲノム
  • バイオマーカー探索
  • その他

第12章 NGSベースのRNAシーケンス市場：エンドユーザー別

  • 市場概要
  • 学術研究機関
  • 製薬・バイオテクノロジー企業
  • 病院とクリニック
  • 受託研究機関
  • その他

第13章 NGSベースのRNAシーケンス市場：コンポーネント別

  • 市場概要
  • ハードウェア
  • ソフトウェア
  • サービス
  • その他

第14章 NGSベースのRNAシーケンス市場：機能別

  • 市場概要
  • 遺伝子発現プロファイリング
  • デノボトランスクリプトームアセンブリ
  • エピジェネティクス
  • その他

第15章 NGSベースのRNAシーケンス市場：展開別

  • 市場概要
  • オンプレミス
  • クラウドベース
  • その他

第16章 NGSベースのRNAシーケンス市場：段階別

  • 市場概要
  • 研究
  • 臨床
  • その他

第17章 NGSベースのRNAシーケンス市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他の中東・アフリカ

第18章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第19章 企業プロファイル

  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • BGI Genomics
  • Qiagen
  • Thermo Fisher Scientific
  • Roche Sequencing Solutions
  • Agilent Technologies
  • PerkinElmer
  • 10x Genomics
  • Bio-Rad Laboratories
  • Genewiz
  • Takara Bio
  • GATC BIoTech
  • Eurofins Genomics
  • Macrogen
  • Novogene
  • Zymo Research
  • Lexogen
  • Singular Genomics
目次
Product Code: GIS10519

NGS Based RNA Sequencing Market is anticipated to expand from $3.31 billion in 2024 to $14.47 billion by 2034, growing at a CAGR of approximately 15.9%. The market encompasses technologies and services that utilize next-generation sequencing for RNA analysis, providing comprehensive insights into gene expression, transcriptomics, and cellular responses. This market is driven by advancements in personalized medicine, biotechnology, and genomic research. Key trends include enhanced sequencing accuracy, reduced costs, and expanded applications in disease diagnosis and drug development, positioning RNA sequencing as a pivotal tool in modern healthcare and life sciences.

Market Overview:

The NGS Based RNA Sequencing Market is experiencing robust expansion, propelled by advancements in genomic research and personalized medicine. The sequencing technology segment emerges as the leading sector, primarily due to its technological superiority and critical role in enabling precise and comprehensive RNA analysis. This segment's dominance is further strengthened by continuous innovations in sequencing platforms, which enhance accuracy, speed, and cost-effectiveness, thereby driving adoption across research and clinical settings. Within this landscape, the single-cell RNA sequencing sub-segment is gaining momentum, offering unprecedented insights into cellular heterogeneity and disease mechanisms. Its potential to revolutionize diagnostics and therapeutic development underscores its impact on the market. Meanwhile, the data analysis and services segment is burgeoning, fueled by the increasing complexity of sequencing data and the demand for sophisticated bioinformatics tools. As these emerging sub-segments mature, they are poised to significantly influence the trajectory of the NGS Based RNA Sequencing Market, fostering innovation and expanding applications.

Market Segmentation
TypeWhole Transcriptome Sequencing, Targeted RNA Sequencing, Small RNA Sequencing, Single-cell RNA Sequencing
ProductSequencing Platforms, Kits and Reagents, Software
ServicesData Analysis, Sequencing Services
TechnologySequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
ApplicationClinical Diagnostics, Drug Discovery and Development, Agricultural Genomics, Biomarker Discovery
End UserAcademic Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Contract Research Organizations
ComponentHardware, Software, Services
FunctionalityGene Expression Profiling, De Novo Transcriptome Assembly, Epigenetics
DeploymentOn-premise, Cloud-based
StageResearch, Clinical

The NGS Based RNA Sequencing Market is predominantly characterized by the dominance of research and academic institutions, followed by clinical and diagnostic laboratories. This distribution is primarily driven by the increasing demand for precise genomic analysis and the growing application of RNA sequencing in personalized medicine. North America remains at the forefront of market adoption, with Europe and Asia-Pacific regions demonstrating significant growth potential due to advancements in healthcare infrastructure and research initiatives. Key players such as Illumina, Thermo Fisher Scientific, and Agilent Technologies are investing in innovative technologies to enhance sequencing accuracy and efficiency. The competitive landscape is further shaped by regulatory frameworks in North America and Europe, which dictate market standards and influence adoption rates. Looking ahead, the market is poised for robust expansion, driven by technological innovations in sequencing platforms and the integration of artificial intelligence for data analysis. However, challenges such as data privacy concerns and the high cost of sequencing technologies persist. Nevertheless, the ongoing advancements in bioinformatics and the increasing demand for precision medicine present substantial opportunities for growth in the NGS Based RNA Sequencing Market.

Geographical Overview:

The NGS Based RNA Sequencing Market is exhibiting substantial growth across various regions, each characterized by unique dynamics. North America dominates the market, propelled by advanced research facilities and significant investments in genomic technologies. The presence of leading biotechnology firms and academic institutions further bolsters this region's market position. Europe follows closely, driven by strong governmental support for research and development in genomics. The region's focus on precision medicine and personalized healthcare enhances its market growth. Collaborative efforts between academic institutions and industry players are pivotal in this expansion. In the Asia Pacific, the market is experiencing rapid growth, fueled by increasing healthcare investments and technological advancements. Countries like China and Japan are at the forefront, investing heavily in biotechnology. The burgeoning demand for personalized medicine contributes to the market's dynamism. Latin America and the Middle East & Africa are emerging markets with growing potential. In Latin America, increasing awareness and investment in genomics are driving market interest. Meanwhile, the Middle East & Africa are recognizing the role of RNA sequencing in advancing healthcare and research capabilities. These regions are poised for significant growth as they continue to invest in genomic technologies.

Recent Development:

The NGS Based RNA Sequencing Market has experienced noteworthy developments in recent months. Illumina announced a strategic partnership with Roche to enhance RNA sequencing capabilities, aiming to accelerate advancements in personalized medicine. Thermo Fisher Scientific introduced an innovative RNA sequencing platform designed to improve accuracy and speed, catering to the growing demand for high-throughput sequencing solutions. Agilent Technologies expanded its portfolio with the acquisition of a leading RNA sequencing analytics company, enhancing its data analysis capabilities and strengthening its market position. In regulatory news, the FDA approved a new RNA sequencing-based diagnostic test, marking a significant milestone in the clinical application of RNA sequencing technologies. Finally, BGI Genomics reported a major investment in expanding its RNA sequencing production facilities, aiming to meet the increasing global demand and improve supply chain resilience. These developments underscore the dynamic nature of the NGS Based RNA Sequencing Market, highlighting opportunities for growth and innovation.

Key Trends and Drivers:

The NGS Based RNA Sequencing Market is experiencing a robust expansion, primarily driven by the escalating demand for personalized medicine and precision oncology. The growing prevalence of chronic diseases necessitates advanced diagnostic tools, propelling the adoption of RNA sequencing technologies. Key trends include the integration of artificial intelligence and machine learning, enhancing data analysis capabilities and enabling more accurate interpretations of complex genomic data. Furthermore, the decreasing costs of sequencing technologies are making RNA sequencing more accessible to a broader range of research institutions and clinical laboratories. This democratization of technology is fostering innovation and encouraging the exploration of novel applications in various fields, including drug discovery and biomarker identification. The rise in collaborative research initiatives, both public and private, is further accelerating advancements in this market. The increasing focus on transcriptomics in understanding gene expression and regulation is also a significant driver. This focus is leading to breakthroughs in identifying therapeutic targets and developing new treatment modalities. Opportunities abound in emerging markets, where healthcare infrastructure is rapidly advancing, and there is a growing emphasis on adopting cutting-edge genomic technologies. Companies investing in user-friendly, scalable sequencing solutions are well-positioned to capitalize on these burgeoning opportunities.

Restraints and Challenges:

The NGS Based RNA Sequencing Market is confronted with several significant restraints and challenges. A primary obstacle is the high cost associated with sequencing technologies, which restricts accessibility for smaller laboratories and institutions. Furthermore, the complexity of data interpretation requires specialized expertise, often necessitating additional investment in training and skilled personnel. Data privacy concerns also pose a challenge, as stringent regulations on genetic information can impede research and collaboration. Additionally, the rapid pace of technological advancements can lead to obsolescence, compelling continuous investment to remain competitive. Finally, the integration of NGS technologies into existing workflows can be cumbersome, requiring substantial time and resources for adaptation. These challenges collectively hinder the widespread adoption and growth of the NGS Based RNA Sequencing Market.

Key Companies:

Illumina, Oxford Nanopore Technologies, Pacific Biosciences, BGI Genomics, Qiagen, Thermo Fisher Scientific, Roche Sequencing Solutions, Agilent Technologies, Perkin Elmer, 10x Genomics, Bio- Rad Laboratories, Genewiz, Takara Bio, GATC Biotech, Eurofins Genomics, Macrogen, Novogene, Zymo Research, Lexogen, Singular Genomics

Sources:

National Center for Biotechnology Information (NCBI), European Molecular Biology Laboratory (EMBL), Genome Canada, National Institutes of Health (NIH), European Bioinformatics Institute (EMBL-EBI), Human Genome Organisation (HUGO), Wellcome Trust Sanger Institute, The Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory (CSHL), University of California, Santa Cruz (UCSC) Genome Browser, National Human Genome Research Institute (NHGRI), The Genome Analysis Centre (TGAC), International Society for Computational Biology (ISCB), American Society of Human Genetics (ASHG), European Society of Human Genetics (ESHG), International Conference on Genomics, Advances in Genome Biology and Technology (AGBT), RNA Society Annual Meeting, International Conference on Systems Biology (ICSB), World Congress on Biotechnology and Genetic Engineering

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: NGS-Based RNA-Sequencing Market Overview

  • 1.1 Objectives of the Study
  • 1.2 NGS-Based RNA-Sequencing Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Deployment
  • 2.12 Key Highlights of the Market, by Stage
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Deployment
  • 3.11 Market Attractiveness Analysis, by Stage
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: NGS-Based RNA-Sequencing Market Outlook

  • 4.1 NGS-Based RNA-Sequencing Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: NGS-Based RNA-Sequencing Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: NGS-Based RNA-Sequencing Market Size

  • 6.1 NGS-Based RNA-Sequencing Market Size, by Value
  • 6.2 NGS-Based RNA-Sequencing Market Size, by Volume

7: NGS-Based RNA-Sequencing Market, by Type

  • 7.1 Market Overview
  • 7.2 Whole Transcriptome Sequencing
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Targeted RNA Sequencing
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Small RNA Sequencing
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Single-cell RNA Sequencing
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Others
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region

8: NGS-Based RNA-Sequencing Market, by Product

  • 8.1 Market Overview
  • 8.2 Sequencing Platforms
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Kits and Reagents
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Software
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: NGS-Based RNA-Sequencing Market, by Services

  • 9.1 Market Overview
  • 9.2 Data Analysis
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Sequencing Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Others
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region

10: NGS-Based RNA-Sequencing Market, by Technology

  • 10.1 Market Overview
  • 10.2 Sequencing by Synthesis
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Ion Semiconductor Sequencing
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Single-molecule Real-time Sequencing
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Nanopore Sequencing
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: NGS-Based RNA-Sequencing Market, by Application

  • 11.1 Market Overview
  • 11.2 Clinical Diagnostics
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Drug Discovery and Development
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Agricultural Genomics
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Biomarker Discovery
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: NGS-Based RNA-Sequencing Market, by End User

  • 12.1 Market Overview
  • 12.2 Academic Research Institutions
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Pharmaceutical and Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Hospitals and Clinics
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Research Organizations
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: NGS-Based RNA-Sequencing Market, by Component

  • 13.1 Market Overview
  • 13.2 Hardware
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Software
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Services
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: NGS-Based RNA-Sequencing Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Gene Expression Profiling
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 De Novo Transcriptome Assembly
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Epigenetics
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: NGS-Based RNA-Sequencing Market, by Deployment

  • 15.1 Market Overview
  • 15.2 On-premise
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Cloud-based
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: NGS-Based RNA-Sequencing Market, by Stage

  • 16.1 Market Overview
  • 16.2 Research
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Clinical
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: NGS-Based RNA-Sequencing Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Component
    • 17.2.9 North America Market Size and Forecast, by Functionality
    • 17.2.10 North America Market Size and Forecast, by Deployment
    • 17.2.11 North America Market Size and Forecast, by Stage
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Component
      • 17.2.9.8 United States Market Size and Forecast, by Functionality
      • 17.2.9.9 United States Market Size and Forecast, by Deployment
      • 17.2.9.10 United States Market Size and Forecast, by Stage
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Component
      • 17.2.10.8 Canada Market Size and Forecast, by Functionality
      • 17.2.10.9 Canada Market Size and Forecast, by Deployment
      • 17.2.10.10 Canada Market Size and Forecast, by Stage
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Component
    • 17.3.9 Europe Market Size and Forecast, by Functionality
    • 17.3.10 Europe Market Size and Forecast, by Deployment
    • 17.3.11 Europe Market Size and Forecast, by Stage
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Component
      • 17.3.10.8 Germany Market Size and Forecast, by Functionality
      • 17.3.10.9 Germany Market Size and Forecast, by Deployment
      • 17.3.10.10 Germany Market Size and Forecast, by Stage
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Component
      • 17.3.11.8 France Market Size and Forecast, by Functionality
      • 17.3.11.9 France Market Size and Forecast, by Deployment
      • 17.3.11.10 France Market Size and Forecast, by Stage
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Component
      • 17.3.12.8 Spain Market Size and Forecast, by Functionality
      • 17.3.12.9 Spain Market Size and Forecast, by Deployment
      • 17.3.12.10 Spain Market Size and Forecast, by Stage
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Component
      • 17.3.13.8 Italy Market Size and Forecast, by Functionality
      • 17.3.13.9 Italy Market Size and Forecast, by Deployment
      • 17.3.13.10 Italy Market Size and Forecast, by Stage
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Component
      • 17.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.9 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.10 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Component
      • 17.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.9 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.10 Sweden Market Size and Forecast, by Stage
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Component
      • 17.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.9 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.10 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Component
      • 17.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.9 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.10 Denmark Market Size and Forecast, by Stage
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Component
      • 17.3.18.8 Finland Market Size and Forecast, by Functionality
      • 17.3.18.9 Finland Market Size and Forecast, by Deployment
      • 17.3.18.10 Finland Market Size and Forecast, by Stage
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Component
      • 17.3.19.8 Russia Market Size and Forecast, by Functionality
      • 17.3.19.9 Russia Market Size and Forecast, by Deployment
      • 17.3.19.10 Russia Market Size and Forecast, by Stage
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Component
      • 17.4.9.8 China Market Size and Forecast, by Functionality
      • 17.4.9.9 China Market Size and Forecast, by Deployment
      • 17.4.9.10 China Market Size and Forecast, by Stage
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Component
      • 17.4.10.8 India Market Size and Forecast, by Functionality
      • 17.4.10.9 India Market Size and Forecast, by Deployment
      • 17.4.10.10 India Market Size and Forecast, by Stage
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Component
      • 17.4.11.8 Japan Market Size and Forecast, by Functionality
      • 17.4.11.9 Japan Market Size and Forecast, by Deployment
      • 17.4.11.10 Japan Market Size and Forecast, by Stage
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Component
      • 17.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.9 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.10 South Korea Market Size and Forecast, by Stage
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Component
      • 17.4.13.8 Australia Market Size and Forecast, by Functionality
      • 17.4.13.9 Australia Market Size and Forecast, by Deployment
      • 17.4.13.10 Australia Market Size and Forecast, by Stage
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Component
      • 17.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.9 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.10 Singapore Market Size and Forecast, by Stage
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Component
      • 17.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.9 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.10 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Component
      • 17.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.9 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.10 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Component
      • 17.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.9 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.10 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Component
    • 17.5.9 Latin America Market Size and Forecast, by Functionality
    • 17.5.10 Latin America Market Size and Forecast, by Deployment
    • 17.5.11 Latin America Market Size and Forecast, by Stage
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Component
      • 17.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.9 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.10 Brazil Market Size and Forecast, by Stage
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Component
      • 17.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.9 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.10 Mexico Market Size and Forecast, by Stage
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Component
      • 17.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.9 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.10 Argentina Market Size and Forecast, by Stage
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Component
      • 17.6.10.8 UAE Market Size and Forecast, by Functionality
      • 17.6.10.9 UAE Market Size and Forecast, by Deployment
      • 17.6.10.10 UAE Market Size and Forecast, by Stage
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Component
      • 17.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.9 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.10 South Africa Market Size and Forecast, by Stage
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Illumina
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Oxford Nanopore Technologies
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Pacific Biosciences
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 BGI Genomics
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Qiagen
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Thermo Fisher Scientific
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Roche Sequencing Solutions
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Agilent Technologies
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 PerkinElmer
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 10x Genomics
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Bio-Rad Laboratories
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Genewiz
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Takara Bio
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 GATC Biotech
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Eurofins Genomics
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Macrogen
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Novogene
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Zymo Research
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Lexogen
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Singular Genomics
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis